| Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma D Huang, Y Ding, M Zhou, BI Rini, D Petillo, CN Qian, R Kahnoski, ... Cancer research 70 (3), 1063, 2010 | 464 | 2010 |
| Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo D Huang, Y Ding, WM Luo, S Bender, CN Qian, E Kort, ZF Zhang, ... Cancer research 68 (1), 81, 2008 | 267 | 2008 |
| Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma D Huang, Y Ding, Y Li, WM Luo, ZF Zhang, J Snider, K VandenBeldt, ... Cancer research 70 (3), 1053, 2010 | 262 | 2010 |
| Anti-tumor activity of a 3-oxo derivative of oleanolic acid D Huang, Y Ding, Y Li, W Zhang, W Fang, X Chen Cancer letters 233 (2), 289-296, 2006 | 114 | 2006 |
| Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer T Ivanova, H Zouridis, Y Wu, LL Cheng, IB Tan, V Gopalakrishnan, ... Gut, 2012 | 108 | 2012 |
| VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma Y Li, ZF Zhang, J Chen, D Huang, Y Ding, MH Tan, CN Qian, JH Resau, ... American journal of translational research 2 (3), 296, 2010 | 60 | 2010 |
| Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice RJ Abi-Habib, R Singh, SH Leppla, JJ Greene, Y Ding, B Berghuis, ... Clinical cancer research 12 (24), 7437-7443, 2006 | 57 | 2006 |
| Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma Y Ding, EA Boguslawski, BD Berghuis, JJ Young, Z Zhang, K Hardy, ... Molecular cancer therapeutics 7 (3), 648-658, 2008 | 53 | 2008 |
| Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets Y Ding, D Huang, Z Zhang, J Smith, D Petillo, BD Looyenga, K Feenstra, ... Cancer research 71 (15), 5225, 2011 | 40 | 2011 |
| MKK signaling and vascularization PE Depeille, Y Ding, JL Bromberg-White, NS Duesbery Oncogene 26 (9), 1290-1296, 2007 | 28 | 2007 |
| The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancer J Fu, Y Ding, D Huang, H Li, X Chen Cancer letters 248 (1), 153-163, 2007 | 19 | 2007 |
| Development of an enzyme-linked immunosorbent assay (ELISA) for the specific detection of MEKK1 expression in cells Y Ding, D Huang, X Chen Journal of pharmacological and toxicological methods 51 (2), 159-167, 2005 | 1 | 2005 |
| Cell and molecular biology of canine angiosarcoma N Andersen, Y Ding, E Boguslawski, R Froman, A Blanski, C Weisner, ... INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 28, S55-S55, 2011 | | 2011 |
| Sunitinib primarily acts on tumor endothelium but not tumor cells to inhibit renal cell carcinoma tumor growth D Huang, Y Ding, Y Li, WM Luo, ZF Zhang, J Snider, K VandenBeldt, ... Cancer Research 70 (8_Supplement), 1644-1644, 2010 | | 2010 |
| Interleukin-8 as a potential mediator for renal cell carcinoma resistance to antiangiogenic sunitinib therapy D Huang, Y Ding, M Zhou, B Rini, D Petillo, CN Qian, R Kahnoski, ... Cancer Research 70 (8_Supplement), 630-630, 2010 | | 2010 |
| MKK signaling is required for fibrosarcoma growth and vascularization. Y Ding, E Boguslawski, B Berghuis, J Young, Z Zhang, N Duesbery Cancer Research 67 (9_Supplement), 323-323, 2007 | | 2007 |
| In vitro and in vivo studies of SU11248 in clear cell renal cell carcinoma D Huang, W Luo, Y Ding, E Kort, CN Qian, B Teh Cancer Research 67 (9_Supplement), 3989-3989, 2007 | | 2007 |
| Inhibition of multiple MKK signaling pathway suppressed renal cell carcinoma growth and angiogenesis in vivo D Huang, Y Ding, W Luo, S Bender, CN Qian, B Berghuis, N Duesbery, ... Cancer Research 67 (9_Supplement), 5413-5413, 2007 | | 2007 |
Dan HuangVan Andel InstituteBestätigte E-Mail-Adresse bei vai.org
